Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When does ozempic go generic?Cosentyx route of administration?Novolog patent expiration?Descovy price in india?Dupixent loss of exclusivity date?
NCT04502433 is listed as a clinical trial involving poractant alfa (a pulmonary surfactant). The trial title is: “Poractant Alfa in the Prevention of Bronchopulmonary Dysplasia in Preterm Infants”.
The study focuses on testing poractant alfa in preterm infants, with an aim tied to reducing the risk of bronchopulmonary dysplasia (BPD).
You can verify the exact wording and other record details directly in the trial registry entry for NCT04502433 (ClinicalTrials.gov). Sources: 1. https://clinicaltrials.gov/ct2/show/NCT04502433
Other Questions About Poractant :